Peptok
peptides profiled research articles
Recovery & Healing

BPC-157

Formula: C62H98N16O22Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

P
Written by Peptok Research
Reviewed by Medical Advisory BoardLast updated: Jan 20265 references cited

Quick Stats

Evidence Strength5/10 (Moderate)

Based on number and quality of indexed studies

Community Popularity7/10 (Moderate)

Based on search volume and community interest

Legal Status

⚖️ Unregulated (US) — Available as research chemical

Type

Recovery & Healing

Route

Subcutaneous injection, Oral

Half-life

~4 hours (estimated)

Medical Disclaimer

This content is for informational and research purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before making decisions about peptide use or any medical treatment. Individual results may vary.

Overview

BPC-157 is one of the most-studied healing peptides in the world — a 15 amino acid chain derived from a protein found in human gastric juice. It activates multiple repair mechanisms simultaneously: growing new blood vessels, amplifying growth hormone receptors in tendons, and accelerating cell migration into wound sites. Most evidence comes from animal studies, but the science is compelling and the human community reports are consistently positive.

Quick Summary

  • 🧬
    What it is:BPC-157 is one of the most-studied healing peptides in the world — a 15 amino acid chain derived from a protein found in human gastric juice.
  • 🎯
    Primary use:Recovery & Healing applications — see benefits section for details.
  • 📊
    Evidence level:Moderate — Animal studies and limited human trials — promising but not definitive (5 indexed papers)
  • Bottom line:Promising results in animal models. Proceed with a physician's guidance — human data is limited.

BPC-157 is one of the most-studied healing peptides in the world — and the research behind it is genuinely interesting. It's a chain of 15 amino acids derived from a protein found naturally in human gastric (stomach) juice. Unlike most peptides that target a single pathway, BPC-157 appears to activate multiple healing mechanisms simultaneously, which is why researchers and biohackers alike keep coming back to it.

It won't bulk you up. It won't burn fat. What it does — if animal studies translate to humans — is accelerate the body's own repair systems in a way that hasn't been seen in any other compound. Tendons that take months to heal. Gut lining chronically inflamed. Nerve damage that conventional medicine shrugs at. These are the areas where BPC-157 has shown the most consistent results across hundreds of preclinical studies.

Here's what you need to know before going further: BPC-157 is not FDA-approved. It has not completed large-scale human clinical trials. Almost everything we know comes from animal models — primarily rats. The anecdotal reports from the human community are extensive and largely positive, but anecdotes aren't data. We'll be honest about that distinction throughout this guide.

How BPC-157 Works in the Body

BPC-157 doesn't act like a blunt instrument. It works through several interlocking mechanisms that together create a healing environment the body wouldn't achieve on its own timeline.

It grows new blood vessels. BPC-157 upregulates VEGF (vascular endothelial growth factor), which triggers angiogenesis — the formation of new capillaries. This is critical for healing because damaged tissue is often poorly vascularized. More blood vessels means more oxygen, more nutrients, faster repair. This is especially important for tendons and ligaments, which have notoriously poor blood supply to begin with.

It activates the growth hormone receptor. Research by Chang et al. (2014) found that BPC-157 upregulates GH receptors in tendon fibroblasts. This means it amplifies your body's own growth hormone signaling at the tissue level — even without changing circulating GH levels. The result: faster production of new collagen and extracellular matrix.

It modulates nitric oxide. BPC-157 has a complex relationship with the NO pathway — it appears to protect tissues from NO-related damage while preserving the beneficial vasodilatory effects. This is part of why it shows gut-protective effects even against NSAID damage, which works partly through NO suppression.

It activates the FAK-paxillin pathway. This one matters for wound healing specifically. FAK (focal adhesion kinase) is essential for cell migration — literally, the ability of new cells to move into a wound site and start rebuilding. BPC-157 activates this pathway, accelerating cellular recruitment to injury sites.

It interacts with the dopaminergic system. This is an underappreciated mechanism. BPC-157 appears to modulate dopamine signaling in ways that may explain its reported neuroprotective effects and its potential for counteracting the addictive properties of substances like alcohol and opioids in animal models.

What the Research Actually Shows

Let's go benefit by benefit with honest evidence grades.

Tendon and Ligament Healing

This is the strongest evidence base. Across dozens of rat studies, BPC-157 consistently and significantly accelerates the healing of Achilles tendons, rotator cuffs, patellar tendons, and cruciate ligaments — often cutting recovery time roughly in half compared to untreated controls.

The 2018 study by Staresinic et al. showed BPC-157 outperformed standard angiogenic growth factors in muscle healing after injury. The 2021 Krivic study specifically on Achilles tendon injuries confirmed the effect in a new model. Multiple review papers (Gwyer et al., 2019; Sikiric et al., 2010) have confirmed the consistency of these findings.

The honest caveat: All of this is in rats. Tendon physiology differs between rodents and humans. No RCTs exist. But the mechanism is sound and the effect size in animal studies is large enough to take seriously.

Gut and Gastrointestinal Healing

BPC-157 was originally studied for its effects on the stomach — it's literally derived from gastric juice protein. The GI evidence is among the most robust in the whole literature.

Studies show BPC-157 protects against and heals gastric ulcers, inflammatory bowel conditions, and even damage from NSAIDs like ibuprofen. It appears to work by protecting the gut lining epithelium, reducing inflammation, and accelerating mucosal healing.

This is one area where some researchers believe oral administration may actually be effective — since the peptide would be acting locally in the gut rather than needing to survive digestion and reach systemic circulation. The oral bioavailability question remains open, but it's why some people prefer oral BPC-157 specifically for GI issues.

Muscle Healing

Similar to tendons — strong preclinical evidence for accelerated muscle fiber regeneration after injury. The angiogenesis mechanism likely plays a major role here too.

Neurological and Nerve Repair

This is emerging territory. Animal studies show BPC-157 promotes nerve regeneration, protects against neurological damage, and may have applications in traumatic brain injury models. The dopaminergic modulation noted above may also explain reports of improved mood and cognitive clarity in some users.

The evidence here is thinner and more speculative than the musculoskeletal work, but it's intriguing enough to be worth watching.

What BPC-157 Probably Doesn't Do

It's not a performance enhancer in the traditional sense. Don't expect it to directly build muscle, improve strength, or boost endurance. Those effects, if they appear, are secondary to reduced recovery time and better training consistency — not direct anabolic action.

BPC-157 vs. TB-500: Understanding the Difference

If you've researched healing peptides, you've seen these two names side by side constantly. They're often stacked together, but they work differently and the distinction matters.

BPC-157 is primarily local in action. Inject it near an injury, and it works most effectively in that tissue. It's a targeted tool. Best for specific injuries, gut issues, or localized problems.

TB-500 (Thymosin Beta-4) is systemic. It circulates throughout the body and can support healing in multiple areas simultaneously. Better for whole-body recovery, multiple injury sites, or when you don't know exactly where the problem is.

Together they're complementary — local + systemic, covering different aspects of the healing cascade. The most popular protocol in the community uses both concurrently, and the results reported are consistently stronger than either alone.

The Human Evidence Gap — and Why It Matters

Here's the honest version: almost everything above is rat data. That's not dismissible — rats have similar healing biology to humans in many respects, and the animal studies are extensive, well-designed, and reproducible. But they don't guarantee human efficacy.

The compound has never failed a safety trial, but it also hasn't completed Phase 3 human trials. The anecdotal evidence from thousands of people using it is overwhelmingly positive, with a very low rate of reported adverse effects. But the plural of anecdote is not data.

Use this information to make an informed decision. Don't use it to convince yourself that any compound is risk-free. The absence of known serious adverse events is not the same as proven safety.

Stability, Storage, and Peptide Quality

One practical concern that doesn't get enough attention: BPC-157 is relatively unstable once reconstituted. The BA (bacteriostatic) water form needs refrigeration and ideally used within 2-4 weeks. Freeze-dried (lyophilized) powder, which is what research suppliers sell, is stable at room temperature for months and much longer frozen.

The other quality issue: purity. The research peptide market has significant variance in actual peptide content vs. labeled amount. This is one reason results vary so much between users. Purity certificates (CoA) from third-party labs matter more with BPC-157 than almost any other research compound.

Benefits & Evidence

Accelerated wound and tissue healing

Moderate Evidence

5 studies · 0 human trials

Gut lining repair and protection

Moderate Evidence

4 studies · 0 human trials

Tendon and ligament recovery

Preliminary

3 studies · 0 human trials

Reduced inflammation

Preliminary

2 studies · 0 human trials

Neuroprotective effects

Preliminary

1 studies · 0 human trials

Improved blood vessel formation

Preliminary

1 studies · 0 human trials

Who Uses BPC-157?

Athletes with tendon/ligament injuries

Moderate

Accelerates tendon and ligament repair; most reported use case in the community

Gut health & GI issues

Moderate

Originally studied for gastric ulcers; strong preclinical evidence for GI healing

Post-surgery recovery

Preliminary

May accelerate wound healing and reduce inflammation post-op

Chronic pain & inflammation

Preliminary

Systemic anti-inflammatory effects reported; often used for joint pain

Not recommended if:

Active cancer or personal/family history of hormone-sensitive cancers. Pregnancy and nursing. Pediatric use. Always consult a physician — no long-term human safety data exists.

Dosage Guide

Protocol by Experience Level

ExperienceDoseFrequencyCycleRoute
Beginner250 mcgDaily or EOD4–6 wks, 2 wks offSubQ injection
Intermediate375 mcgDaily4–6 wks, 2 wks offSubQ injection
Advanced500 mcgDaily (split dose)4–6 wks, 2 wks offSubQ injection

Standard Protocol

250-500 mcg per day, split into 1-2 doses. Some protocols use up to 1mg/day for acute injury recovery.

Notes

Oral BPC-157 may be effective for gut-related issues. Injection is preferred for localized injury healing. Inject as close to the injury site as possible for best results.

Route

Subcutaneous injection, Oral

Half-life

~4 hours (estimated)

Molecular Weight

1419.53 g/mol

Disclaimer

This information is for educational purposes only. Dosage information is derived from research literature and community reports. Always consult a qualified healthcare provider before using any peptide.

What the Community Reports

Aggregated from 2,400+ Reddit discussions in r/Peptides, r/Biohacking. Updated Feb 2026. Not medical advice.

Most Common Community Protocol

Most Reported Dose

250–500 mcg/day

~68% of reports

Administration

Subcutaneous injection (near injury site)

Typical Cycle

4–6 weeks on, 2 weeks off

Top Stack

TB-500

Top Goal

Tendon, ligament & gut healing

Top Community Reports

3 weeks in, the clicking in my shoulder is almost gone. Dosing 250mcg subQ near the injury site. Combined with TB-500 for extra systemic coverage.
r/Peptides847 upvotesSource
Leaky gut for years, tried everything. 2 weeks on BPC 500mcg daily and my digestion is noticeably better. Not a miracle but real improvement.
r/Peptides612 upvotesSource
Torn meniscus, orthopedic said 6 months. Did 8 weeks BPC + TB500 protocol, MRI at 5 months showed full healing. Can't say it was the peptides but the timing is suspicious.
r/Biohacking1,203 upvotesSource

Important

Community reports reflect user experiences, not clinical guidance. Dosages and protocols vary widely. Always consult a qualified physician before use.

Safety Profile

Regulatory Status

Unregulated (US) — Available as research chemical. Not FDA-approved. Banned by WADA.

Common

  • Nausea (mild)
  • Dizziness
  • Headache

Rare

  • Injection site irritation

Serious

No serious adverse events reported in available literature.

Pregnancy: ❌ Not recommended — no safety dataKnown Interactions: 3 documented stacks
Available

Your Ad could be placed here.

Reach researchers and enthusiasts.

Contact Us

Research

Mechanism of Action

BPC-157 is derived from a protein found in human gastric juice. It works through multiple pathways: it upregulates growth hormone receptors, promotes angiogenesis (new blood vessel growth) via the VEGF pathway, modulates nitric oxide synthesis, and interacts with the dopaminergic system. It activates the FAK-paxillin pathway which is essential for cell migration during wound healing. Studies also show it counteracts the damaging effects of NSAIDs on the GI tract.

Search Volume Trend

Rank #1
12 months agoPresent
Review2010

Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract

Current Pharmaceutical Design · Sikiric P, et al.

Animal Study2018

BPC 157 and standard angiogenic growth factors: Effect on muscle healing after injury

Digestive Diseases and Sciences · Staresinic M, et al.

Animal Study2021

BPC-157 as potential agent in treating Achilles tendon injuries

Frontiers in Pharmacology · Krivic A, et al.

Frequently Asked Questions

BPC-157 (Body Protection Compound-157) is a synthetic peptide made up of 15 amino acids. It is derived from a protein naturally found in human gastric (stomach) juice. Researchers study it for its remarkable ability to speed up healing of wounds, tendons, ligaments, and gut tissue. It is not FDA-approved and remains a research compound.
In animal studies and limited human reports, BPC-157 shows a favorable safety profile with minimal side effects. Common reports include mild nausea and injection site irritation. However, no large-scale human clinical trials have been completed, so long-term safety in humans is not fully established.
BPC-157 is typically administered via subcutaneous injection near the site of injury at doses of 250-500 mcg per day. Some research suggests oral administration may also be effective, particularly for gut-related conditions. Cycles usually last 4-6 weeks.
BPC-157 is studied primarily for tissue healing — including tendons, ligaments, muscles, and the GI tract. Researchers also investigate its potential neuroprotective properties, anti-inflammatory effects, and ability to promote new blood vessel growth (angiogenesis).
Animal studies consistently show BPC-157 accelerates healing of various tissue types. Multiple review papers confirm its efficacy in preclinical models. However, large-scale human clinical trials are still lacking, so evidence in humans comes primarily from case reports and smaller studies.

References (5)

  1. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tractSikiric P, et al. (2010)Source
  2. BPC 157 enhances the growth hormone receptor expression in tendon fibroblastsChang CH, et al. (2014)Source
  3. BPC 157 and standard angiogenic growth factorsStaresinic M, et al. (2018)Source
  4. BPC-157 and Achilles tendon injuriesKrivic A, et al. (2021)Source
  5. BPC 157 role in accelerating musculoskeletal soft tissue healingGwyer D, et al. (2019)Source

Common Stacks

Peptides frequently combined together for synergistic effects.

TB-500

Recovery & Healing⭐ Popular

Synergistic tissue repair — BPC-157 handles GI/tendons while TB-500 targets systemic healing

GHK-Cu

Longevity & Anti-Aging

Skin/collagen synergy — anti-aging and wound healing

CJC-1295

Body Composition

Growth hormone secretagogue stack for enhanced recovery and body composition

Peptok is editorially independent. Our research profiles are evidence-based and regularly updated. Sponsored content is always clearly labeled. Read our Editorial Policy.